EAVI2020 EAVI2020 on Twitter EAVI2020 on Facebook EAVI2020 on LinkedIn

Archive: Sep 2019


    Leave a Comment

    Register for an all-star cast roundtable discussion

    Developing an effective #HIV vaccine: what do we need and when will we get there?

    First attempts to develop a vaccine against HIV started in the 1980s. Thirty years on and we still do not have a viable vaccine. Why has it been so difficult? What is needed to realise the goal of an effective vaccine? Is the development of a vaccine still a priority? Researchers from EAVI2020 – a €23 million EU-funded research initiative to accelerate the search for an effective HIV vaccine – will tackle these challenging questions in a roundtable discussion.

    Panellists include:

    • Facilitator, Dr Roger Tatoud – International AIDS Society
    • Prof Robin Shattock – Imperial College London
    • Dr Roger le Grand – Commissariat à l’ énergie atomique et aux énergies alternatives (CEA)
    • Susan Barnett – Bill & Melinda Gates Foundation
    • Athina Kilpelainen – Vall d’Hebron Institut de Recerca

    Tune in to our esteemed researchers & experts roundtable discussion on 24 Oct @ 17:00 (CEST).

    Any queries, email EAVI2020 at hello@eavi2020.org

    Have a question for the panel? Register for the webinar now

    Register before 18 October to submit your question to the panel.


  2. Job opportunity: Research fellow position @ VET, San Raffaele Scientific Institute

    Leave a Comment

    Applications are invited for a research fellow position immediately available at the Viral Evolution and Transmission Unit at San Raffaele Scientific Institute in Milano.

    The position is open to a motivated young fellow to work on a project on the role of antibodies in mediating HIV-1 transmission at mucosal sites. The selected candidate will work with in vitro and ex vivo human tissue models to analyse with immunofluorescence and confocal microscopy techniques the very first events of HIV infection at the mucosal site, and the role of antibodies in changing the viral path. Results emerging from these studies will yield precious information on pathways of infection as well as the immune subversions following thereafter allowing HIV to replicate or escape the immune response. This new knowledge may drive improved vaccination strategies apt at inducing the relevant mucosal antibodies effective for prevention.

    The applicant should preferably have a good knowledge base in one of the following areas: 1) Cell Biology (cell culture, confocal microscopy); 2) Virology (viral infection, titration); 3) Immunology (ELISA, flow cytometry).

    The selected candidate will mainly work in a Biosafety level 3 laboratory. There will be opportunities to interact and work with international and national colleagues, and attend scientific conferences. Writing manuscripts and applying for independent research grants will be strongly encouraged. Good English knowledge is a must.

    Information on the group’s activities are available at: http://research.hsr.it/en/divisions/immunology-transplantation-and-infectious-diseases/viral-evolution-and-transmission.html.


    To apply please, submit a cover letter with your motivation and fit for the project, and the complete curriculum vitae to <gabriella.scarlatti@hsr.it>.